CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the impact of a new decision by ...

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a leader in artificial intelligence and precision medicine, today announced it has received 510(k) clearance from the U.S. Food and Drug ...

MADRID — A simple home-based screening strategy that involved wearing an ECG patch for 14 days increased the diagnosis of atrial fibrillation (AF) and associated use of anticoagulants in patients at ...

Please provide your email address to receive an email when new articles are posted on . Two studies found that mass screening for atrial fibrillation in older adults does not reduce stroke. In one ...

A mail-based atrial fibrillation (AF) screening programme with ECG-patch monitoring led to a modest long-term increase in AF diagnosis and anticoagulation exposure in older patients at ...

Please provide your email address to receive an email when new articles are posted on . An analysis of five ECG-capable smartwatches found comparable sensitivity and specificity for detection of ...

(RTTNews) - Tempus AI, Inc (TEM), Wednesday announced that the company has received 510(k) clearance from the U.S. Food and Drug Administration for its Tempus ECF-AF, which utilizes AI to detect ...

MADRID, Spain—The use of a noninvasive ECG patch modestly increases the detection of atrial fibrillation (AF) and treatment with anticoagulant therapy among patients at moderate to high risk for ...

Researchers sought to determine the ability of a validated ECG-based AI model for AF risk prediction to determine future incidence of HF and stroke.

Chronic conditions like diabetes or hypertension "often require long-term care through long-term monitoring," observed a researcher, and "we know that continuous monitoring is superior to intermittent ...